Outcomes in high-risk subgroups after ibrutinib and venetoclax for CLL | Ryan Jacobs, MD | EHA 2024 

Dr. Ryan Jacobs presents about treatment for previously untreated CLL patients.
The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/
Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: give.healthtre...
HealthTree Cure Hub helps you find your best treatment options and accelerate cure for blood cancers. Join today at www.healthtree...